the UK: reimbursement, and what it actually costs here
the UK: reimbursement, and what it actually costs here. I have gone back and forth on this for months.
Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.
Marketing authorisation is granted centrally for these products; reimbursement, pricing and prescribing criteria are national competences. Those are decided by different bodies with different processes.
Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.
If two or three other people have done the same thing we might actually learn something. Alone it is an anecdote.
best — the order this archive was captured in
Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.
cross-border prescription rules exist and they are narrower than people think
Same. Naming the country in the first line would fix most of the bad advice on this board.
keep the prescription and the receipt, both matter for claims
I would not treat one pharmacy’s quote as a national price. The variation within a country is often larger than between them.
I would not treat one pharmacy’s quote as a national price.
This is the split the whole board depends on. Authorisation is European; payment is national.
Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.
Published reimbursement criteria exist in most member states and are usually available in the national language.
Adding the practical step — read your own country’s published criteria. They exist and they are definitive.
[deleted]
reimbursement is national, not European, and that is the whole board
reimbursement is national, not European, and that is the whole board
Disagreeing with this bit: that criterion belongs to one member state and is being quoted as general.
the reimbursement criteria are published in most member states
Is this a cross-border question or a domestic one?
private pricing varies enormously between neighbouring countries
A supply notice in one member state made the front page here and had no effect at all where I am.
Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.
Apotheke pricing and pharmacy pricing elsewhere are different systems
Yes — keep both the prescription and the receipt. Claims processes ask for both and never at a convenient moment.
That is an authorisation question and you have answered a reimbursement one. They are decided by different bodies.
- 1Published reimbursement criteria exist in most member states and are usually…8 comments in this branch · started by u/spain_receta